緊急避妊薬市場：タイプ、カテゴリー、年齢層、分布別-2025-2030年世界予測

緊急避妊薬市場は、2023年に10億2,000万米ドルと評価され、2024年には10億8,000万米ドルに達すると予測され、CAGR 6.49％で成長し、2030年には15億8,000万米ドルになると予測されています。

緊急避妊薬（ECPs）は、幅広い避妊薬市場の中でも重要なセグメントであり、主に意図しない妊娠を防ぐために性交後に使用されます。ECPには、レボノルゲストレルや酢酸ウリプリスタルを含むホルモン製剤が含まれ、これらは性交後72時間から120時間以内に最も効果を発揮します。ECPの必要性は、一次避妊法が失敗した場合のセーフティーネットとして機能することで、中絶率を減少させるという役割によって強調されています。ECPは主に、避妊に失敗した場合、無防備な性交、性的暴行の場合に使用されます。最終用途の範囲は様々な人口統計に及び、主に先進地域と発展途上地域の両方で生殖年齢の女性を対象としています。市場成長の主因は、認知度の向上と入手のしやすさ、特にいくつかの地域における店頭販売によるものです。女性のリプロダクティブ・ヘルス（性と生殖に関する健康）と自律性への注目の高まりが需要をさらに促進しています。しかし、文化的・宗教的な反対、安全性と有効性に関する誤った情報、地域によっては規制上の障壁が成長の課題となっています。潜在的なビジネスチャンスは、啓発キャンペーンを拡大し、教育のためにデジタルプラットフォームを活用することにあります。また、十分な情報に基づいた意思決定と幅広いアクセスを確保するためのヘルスケアプロバイダーとの連携も、市場浸透を高める可能性があります。イノベーションの焦点としては、有効期間を延長した製剤の改良、環境意識の高い消費者にアピールするための生分解性包装の調査などが考えられます。市場は本来、社会情勢や法制度の動向に敏感であり、順応性の必要性が浮き彫りになっています。障壁はあるもの、包括的家族計画の一環として緊急避妊が受け入れられつつあることは、ビジネス成長の有望な道を示しています。エビデンスに基づく教育を重視し、支持的な政策を求めてロビー活動を行うことで、課題を軽減できる可能性があります。この市場のダイナミックな性質は、ECPの受け入れと使用を支援する環境を醸成するために、消費者との継続的な関わりと戦略的パートナーシップの重要性を強調しています。

市場力学：急速に進化する緊急避妊薬市場の主要市場インサイトを公開

緊急避妊薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 米国における意図しない妊娠に起因する採用の増加。
  • 避妊ピルの使用を促進する政府の取り組み
• 市場抑制要因
  • 有効性に関する問題、緊急避妊薬のリコール問題
• 市場機会
  • メーカーによる研究開発と共同啓発キャンペーンの増加
  • オンラインチャネルによる容易な入手
• 市場の課題
  • 緊急避妊薬摂取に伴う副作用の可能性

ポーターの5つの力：緊急避妊薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、緊急避妊薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：緊急避妊薬市場における外部からの影響の把握

外部マクロ環境要因は、緊急避妊薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析緊急避妊薬市場における競合情勢の把握

緊急避妊薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス緊急避妊薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、緊急避妊薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨緊急避妊薬市場における成功への道筋を描く

緊急避妊薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 米国では望まない妊娠による養子縁組が増加
    • 避妊薬の使用を促進する政府の取り組み
  • 抑制要因
    • 緊急避妊薬の有効性とリコールの発生率に関する問題
  • 機会
    • メーカーによる研究開発と共同啓発キャンペーンの強化
    • オンラインチャネルを通じて簡単に入手可能
  • 課題
    • 緊急避妊薬の摂取に伴う可能性のある副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 緊急避妊薬市場：タイプ別

• 抗プロゲスチン
• 複合薬
• プロゲステロン錠剤

第7章 緊急避妊薬市場：カテゴリ別

• ブランド
• ジェネリック

第8章 緊急避妊薬市場：年齢層別

• 15-24
• 25-34
• 35-44
• 45歳以上

第9章 緊急避妊薬市場配布元

• オフライン
• オンライン

第10章 南北アメリカの緊急避妊薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の緊急避妊薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの緊急避妊薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 米国政府は避妊へのアクセスを拡大する大統領令に署名した
  • ゲデオン・リヒター、コンシリエント・ヘルスから経口避妊薬の領域を買収
  • ヘルスケアのスタートアップ企業が破産した避妊薬提供者の患者記録を取得
  • モーニングアフターピルブランドが小売店へのアクセスを迅速化し、1パックあたりの供給量を2倍に
  • Curae Pharma360は、医薬品への公平で信頼できるアクセスを促進するためにOTC緊急避妊薬を発売し、十分なサービスを受けていない女性に医療を届けるためにDirect Reliefと提携しました。
  • オーロビンド・ファーマ、避妊薬で米国FDAの承認を取得
  • ペリゴのHRAファーマ、初のOTC避妊薬のFDA申請を提出
  • ルピン、ジェネリック避妊薬メルゼカプセルを米国で発売
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Afaxys Pharma, LLC
• Amneal Pharmaceuticals, Inc.
• Apotex Inc.
• Aurobindo Pharma Limited
• Bayer AG
• Bionpharma Inc.
• Cipla Limited
• Combe Incorporated
• Curae Pharma360 Inc.
• Foundation Consumer Healthcare, LLC
• Gedeon Richter PLC
• Glenmark Pharmaceuticals Limited
• Julie Product Inc.
• Lupin Limited
• Mankind Pharma Ltd.
• Merck & Co., Inc.
• Northstar Rx LLC
• Perrigo Company plc
• Pfizer, Inc.
• Piramal Enterprises Ltd.
• Rapha Pharmaceuticals, Inc.
• Sun Pharmaceutical Industries Limited
• Syzygy Healthcare Solutions, LLC
• Viatris Inc.
• Wockhardt USA LLC
• Xiromed, LLC

LIST OF FIGURES

• FIGURE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
• FIGURE 2. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EMERGENCY CONTRACEPTIVE PILLS MARKET DYNAMICS
• TABLE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ANTIPROGESTIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 37. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 38. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 57. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 59. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 60. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 61. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 63. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 64. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 130. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 132. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 133. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 146. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 148. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 149. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 152. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 153. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 190. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

The Emergency Contraceptive Pills Market was valued at USD 1.02 billion in 2023, expected to reach USD 1.08 billion in 2024, and is projected to grow at a CAGR of 6.49%, to USD 1.58 billion by 2030.

Emergency contraceptive pills (ECPs) represent a critical segment of the broader contraceptive market, primarily used post-coitus to prevent unintended pregnancies. The scope of ECPs encompasses hormonal formulations, including levonorgestrel and ulipristal acetate, which are most effective within 72 to 120 hours post-intercourse. The necessity for ECPs is underscored by their role in reducing abortion rates by serving as a safety net when primary contraceptive methods fail. They are predominantly applied in cases of contraceptive failure, unprotected intercourse, or sexual assault. The end-use scope extends across various demographics, predominantly targeting women of reproductive age in both developed and developing regions. Market growth is primarily driven by increased awareness and accessibility, particularly through over-the-counter availability in several regions. Rising focus on women's reproductive health and autonomy further fuels demand. However, growth is challenged by cultural and religious opposition, misinformation regarding safety and efficacy, and regulatory barriers in certain geographies. Potential opportunities lie in expanding awareness campaigns and leveraging digital platforms for education. Collaborations with healthcare providers to ensure informed decisions and broader access could also enhance market penetration. Innovations can focus on enhanced formulations offering extended efficacy windows, and research into biodegradable packaging to appeal to eco-conscious consumers. The market is inherently sensitive to social and legislative developments, highlighting the need for adaptability. Despite the barriers, the increasing acceptance of emergency contraception as part of comprehensive family planning presents a promising avenue for business growth. Emphasizing evidence-based education and lobbying for supportive policies could mitigate challenges. The market's dynamic nature underscores the importance of continuous consumer engagement and strategic partnerships to foster a supportive environment for ECP acceptance and use.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising adoption owing to unintended pregnancies in the U.S.
  • Government initiatives to promote use of contraceptive pills
• Market Restraints
  • Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
• Market Opportunities
  • Increasing R&D and collaborative awareness campaigns by manufacturers
  • Easy availability through online channel
• Market Challenges
  • Probable side effects associated with consuming emergency contraceptive pills

Porter's Five Forces: A Strategic Tool for Navigating the Emergency Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Emergency Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Emergency Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Emergency Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Emergency Contraceptive Pills Market

A detailed market share analysis in the Emergency Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Emergency Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Emergency Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Emergency Contraceptive Pills Market

A strategic analysis of the Emergency Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emergency Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Curae Pharma360 Inc., Foundation Consumer Healthcare, LLC, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer, Inc., Piramal Enterprises Ltd., Rapha Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Viatris Inc., Wockhardt USA LLC, and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Emergency Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Antiprogestin, Combination Pills, and Progesterone Pills.
• Based on Category, market is studied across Branded and Generic.
• Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
• Based on Distribution, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising adoption owing to unintended pregnancies in the U.S.
    • 5.1.1.2. Government initiatives to promote use of contraceptive pills
  • 5.1.2. Restraints
    • 5.1.2.1. Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D and collaborative awareness campaigns by manufacturers
    • 5.1.3.2. Easy availability through online channel
  • 5.1.4. Challenges
    • 5.1.4.1. Probable side effects associated with consuming emergency contraceptive pills
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Emergency Contraceptive Pills Market, by Type

• 6.1. Introduction
• 6.2. Antiprogestin
• 6.3. Combination Pills
• 6.4. Progesterone Pills

7. Emergency Contraceptive Pills Market, by Category

• 7.1. Introduction
• 7.2. Branded
• 7.3. Generic

8. Emergency Contraceptive Pills Market, by Age Group

• 8.1. Introduction
• 8.2. 15-24
• 8.3. 25-34
• 8.4. 35-44
• 8.5. 45 and Above

9. Emergency Contraceptive Pills Market, by Distribution

• 9.1. Introduction
• 9.2. Offline
• 9.3. Online

10. Americas Emergency Contraceptive Pills Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Emergency Contraceptive Pills Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Emergency Contraceptive Pills Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Government of the United States Signed an Executive Order Expanding Access to Birth Control
  • 13.3.2. Gedeon Richter Acquires Oral Contraceptive Range from Consilient Health
  • 13.3.3. Health-Care Startup Up Acquires Patient Records of Bankrupt Birth Control Provider
  • 13.3.4. Morning After Pill Brand Speeds Up Retail Access, Doubles Supply Per Pack
  • 13.3.5. Curae Pharma360 Launches OTC Emergency Contraception to Advance Equitable, Reliable Access to Medicines; Partners with Direct Relief to Reach Underserved Women
  • 13.3.6. Aurobindo Pharma Receives USFDA Nod for Contraceptives
  • 13.3.7. Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
  • 13.3.8. Lupin Launches Generic Contraceptive Drug Merzee Capsules in U.S.
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Afaxys Pharma, LLC
• 3. Amneal Pharmaceuticals, Inc.
• 4. Apotex Inc.
• 5. Aurobindo Pharma Limited
• 6. Bayer AG
• 7. Bionpharma Inc.
• 8. Cipla Limited
• 9. Combe Incorporated
• 10. Curae Pharma360 Inc.
• 11. Foundation Consumer Healthcare, LLC
• 12. Gedeon Richter PLC
• 13. Glenmark Pharmaceuticals Limited
• 14. Julie Product Inc.
• 15. Lupin Limited
• 16. Mankind Pharma Ltd.
• 17. Merck & Co., Inc.
• 18. Northstar Rx LLC
• 19. Perrigo Company plc
• 20. Pfizer, Inc.
• 21. Piramal Enterprises Ltd.
• 22. Rapha Pharmaceuticals, Inc.
• 23. Sun Pharmaceutical Industries Limited
• 24. Syzygy Healthcare Solutions, LLC
• 25. Viatris Inc.
• 26. Wockhardt USA LLC
• 27. Xiromed, LLC